Matinas BioPharma Holdings (MTNB) Preferred Dividend Payments (2016 - 2021)
Matinas BioPharma Holdings (MTNB) reported Preferred Dividend Payments of $201.0 for Q4 2021, down 99.91% year-over-year from $218050.0 in Q4 2020, and down 99.89% quarter-over-quarter from $184899.0 in Q2 2021.
Matinas BioPharma Holdings (MTNB) Preferred Dividend Payments (2016 - 2021) Analysis & Trends
Matinas BioPharma Holdings (MTNB) has 6 years of Preferred Dividend Payments data on file, last reported at $201.0 in Q4 2021.
- Preferred Dividend Payments for Q4 2021 came in at $201.0, down 99.91% year-over-year; the trailing twelve-month figure through Dec 2021 was $396000.0 (down 50.09% YoY), and the FY2021 annual result was $396000.0, down 50.09% from the prior year.
- Preferred Dividend Payments declined to $201.0 in Q4 2021 per MTNB's latest filing, from $184899.0 in the prior quarter.
- Over five years, Preferred Dividend Payments peaked at $227600.0 in Q3 2020 and troughed at $201.0 in Q4 2021.
- A 5-year average of $151335.7 and a median of $149036.0 in 2017 frame the typical range for Preferred Dividend Payments.
- The sharpest annual moves came in 2020 and 2021: Preferred Dividend Payments soared 405.32% in 2020, then sank 99.91% in 2021.
- A 5-year view of Preferred Dividend Payments shows it stood at $146157.0 in 2017, then gained by 0.43% to $146786.0 in 2018, then tumbled by 69.32% to $45041.0 in 2019, then soared by 384.11% to $218050.0 in 2020, then slumped by 99.91% to $201.0 in 2021.
- Business Quant data shows MTNB's Preferred Dividend Payments at $201.0 in Q4 2021, $184899.0 in Q2 2021, and $210900.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Matinas BioPharma Holdings | 4.60 Mn | 2.15 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 201.00 |
| Jun 30, 2021 | 184,899.00 |
| Mar 31, 2021 | 210,900.00 |
| Dec 31, 2020 | 218,050.00 |
| Sep 30, 2020 | 227,600.00 |
| Jun 30, 2020 | 177,092.00 |
| Mar 31, 2020 | 170,700.00 |
| Sep 30, 2019 | 45,041.00 |
| Jun 30, 2019 | 146,786.00 |
| Mar 31, 2019 | 146,786.00 |
| Dec 31, 2018 | 146,786.00 |
| Sep 30, 2018 | 146,786.00 |
| Jun 30, 2018 | 146,786.00 |
| Mar 31, 2018 | 147,286.00 |
| Dec 31, 2017 | 146,157.00 |
| Sep 30, 2017 | 150,786.00 |
| Jun 30, 2017 | 152,400.00 |
| Mar 31, 2017 | 159,000.00 |
| Sep 30, 2016 | 4.39 Mn |